| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Hypertrophic | 94 | 2024 | 1313 | 5.460 |
Why?
|
| Cardiomyopathy, Dilated | 50 | 2023 | 829 | 4.620 |
Why?
|
| Sarcomeres | 39 | 2022 | 368 | 3.170 |
Why?
|
| Myosin Heavy Chains | 40 | 2024 | 405 | 2.620 |
Why?
|
| Myocardium | 85 | 2024 | 4725 | 2.570 |
Why?
|
| Cardiomyopathies | 28 | 2023 | 1964 | 2.260 |
Why?
|
| Myocytes, Cardiac | 47 | 2024 | 1668 | 2.010 |
Why?
|
| Heart Defects, Congenital | 38 | 2024 | 4696 | 2.010 |
Why?
|
| Mutation | 154 | 2024 | 30045 | 1.830 |
Why?
|
| Muscle Proteins | 18 | 2024 | 1154 | 1.720 |
Why?
|
| Mutation, Missense | 41 | 2023 | 2571 | 1.670 |
Why?
|
| Ventricular Myosins | 13 | 2018 | 65 | 1.530 |
Why?
|
| Myocardial Contraction | 33 | 2021 | 1517 | 1.480 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 13 | 2018 | 63 | 1.440 |
Why?
|
| T-Box Domain Proteins | 17 | 2022 | 469 | 1.360 |
Why?
|
| Heterozygote | 31 | 2021 | 2803 | 1.250 |
Why?
|
| Heart | 36 | 2024 | 4405 | 1.230 |
Why?
|
| RNA Splicing | 9 | 2023 | 918 | 1.190 |
Why?
|
| Induced Pluripotent Stem Cells | 17 | 2024 | 1860 | 1.170 |
Why?
|
| Multienzyme Complexes | 11 | 2008 | 666 | 1.130 |
Why?
|
| Cardiac Myosins | 10 | 2024 | 128 | 1.110 |
Why?
|
| Carrier Proteins | 33 | 2024 | 4936 | 1.110 |
Why?
|
| Heart Ventricles | 32 | 2023 | 3816 | 1.060 |
Why?
|
| RNA | 10 | 2023 | 2723 | 1.000 |
Why?
|
| Pedigree | 78 | 2023 | 4589 | 0.990 |
Why?
|
| Atrial Natriuretic Factor | 21 | 2012 | 350 | 0.980 |
Why?
|
| Twins, Monozygotic | 3 | 2021 | 470 | 0.950 |
Why?
|
| Genes | 62 | 2009 | 1844 | 0.910 |
Why?
|
| Mice | 253 | 2024 | 81509 | 0.910 |
Why?
|
| Genetic Linkage | 44 | 2015 | 2382 | 0.860 |
Why?
|
| Trypan Blue | 1 | 2022 | 22 | 0.850 |
Why?
|
| Lamin Type A | 4 | 2017 | 189 | 0.850 |
Why?
|
| Base Sequence | 97 | 2018 | 12450 | 0.830 |
Why?
|
| Hearing Loss, Sensorineural | 11 | 2010 | 781 | 0.810 |
Why?
|
| Chromosome Mapping | 53 | 2018 | 4638 | 0.810 |
Why?
|
| Animals | 310 | 2024 | 168441 | 0.800 |
Why?
|
| Sequence Analysis, RNA | 17 | 2022 | 2020 | 0.800 |
Why?
|
| Sucrose | 1 | 2022 | 158 | 0.790 |
Why?
|
| Myosins | 23 | 2019 | 405 | 0.790 |
Why?
|
| High-Throughput Nucleotide Sequencing | 15 | 2021 | 3639 | 0.760 |
Why?
|
| Solitary Nucleus | 1 | 2021 | 54 | 0.740 |
Why?
|
| Genetic Variation | 28 | 2021 | 6581 | 0.740 |
Why?
|
| Homeodomain Proteins | 20 | 2016 | 2416 | 0.730 |
Why?
|
| Haploinsufficiency | 8 | 2021 | 337 | 0.730 |
Why?
|
| Chagas Disease | 4 | 2023 | 167 | 0.720 |
Why?
|
| Trypanosoma cruzi | 4 | 2023 | 206 | 0.710 |
Why?
|
| Troponin T | 14 | 2022 | 779 | 0.690 |
Why?
|
| Calsequestrin | 6 | 2014 | 30 | 0.690 |
Why?
|
| Sequence Analysis, DNA | 18 | 2018 | 4741 | 0.690 |
Why?
|
| Exons | 11 | 2021 | 2393 | 0.660 |
Why?
|
| Calcium | 38 | 2021 | 5727 | 0.650 |
Why?
|
| Receptors, Antigen, T-Cell | 33 | 1994 | 2549 | 0.650 |
Why?
|
| Glycogen Storage Disease Type IIb | 5 | 2023 | 18 | 0.640 |
Why?
|
| Echocardiography | 26 | 2021 | 4991 | 0.630 |
Why?
|
| H-2 Antigens | 19 | 1986 | 358 | 0.630 |
Why?
|
| Bromodeoxyuridine | 2 | 2016 | 311 | 0.610 |
Why?
|
| Epigenesis, Genetic | 7 | 2023 | 3798 | 0.600 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2023 | 71 | 0.600 |
Why?
|
| Glycogen Storage Disease | 5 | 2007 | 41 | 0.600 |
Why?
|
| Transcription Factors | 32 | 2024 | 12125 | 0.590 |
Why?
|
| Cardiomegaly | 15 | 2023 | 591 | 0.580 |
Why?
|
| Genes, Dominant | 19 | 2016 | 863 | 0.580 |
Why?
|
| Gene Expression Regulation | 48 | 2021 | 11902 | 0.560 |
Why?
|
| Disease Models, Animal | 44 | 2022 | 18247 | 0.560 |
Why?
|
| Gene Expression Profiling | 18 | 2020 | 9418 | 0.550 |
Why?
|
| Lysosomes | 2 | 2023 | 923 | 0.550 |
Why?
|
| Arrhythmias, Cardiac | 11 | 2021 | 2246 | 0.550 |
Why?
|
| Genes, MHC Class II | 18 | 1987 | 451 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 36 | 2021 | 17912 | 0.540 |
Why?
|
| Alleles | 28 | 2017 | 6922 | 0.540 |
Why?
|
| Point Mutation | 17 | 2020 | 1596 | 0.540 |
Why?
|
| Fibrosis | 15 | 2024 | 2048 | 0.540 |
Why?
|
| Genetic Testing | 14 | 2019 | 3538 | 0.530 |
Why?
|
| Ear, External | 3 | 2022 | 165 | 0.530 |
Why?
|
| Humans | 372 | 2024 | 761423 | 0.530 |
Why?
|
| Phenotype | 64 | 2024 | 16606 | 0.530 |
Why?
|
| Founder Effect | 4 | 2022 | 186 | 0.520 |
Why?
|
| Calcium-Binding Proteins | 10 | 2020 | 1069 | 0.510 |
Why?
|
| Protein Kinases | 8 | 2022 | 1607 | 0.500 |
Why?
|
| Gene Expression Regulation, Developmental | 14 | 2024 | 3612 | 0.500 |
Why?
|
| Gene Library | 5 | 2013 | 1059 | 0.490 |
Why?
|
| Steroid 21-Hydroxylase | 9 | 1992 | 35 | 0.480 |
Why?
|
| Heart Conduction System | 9 | 2017 | 1010 | 0.480 |
Why?
|
| Tropomyosin | 9 | 2010 | 104 | 0.470 |
Why?
|
| Cell Nucleus | 4 | 2022 | 2908 | 0.470 |
Why?
|
| Myocardial Ischemia | 7 | 2021 | 2110 | 0.460 |
Why?
|
| Troponin I | 10 | 2022 | 651 | 0.460 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 629 | 0.460 |
Why?
|
| Benzylamines | 4 | 2019 | 247 | 0.450 |
Why?
|
| Hypertrophy, Left Ventricular | 13 | 2021 | 851 | 0.450 |
Why?
|
| Uracil | 4 | 2019 | 207 | 0.440 |
Why?
|
| Gene Regulatory Networks | 8 | 2022 | 1743 | 0.440 |
Why?
|
| Microscopy, Fluorescence | 2 | 2021 | 2645 | 0.430 |
Why?
|
| Mice, Transgenic | 44 | 2019 | 9535 | 0.430 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 4 | 2010 | 182 | 0.430 |
Why?
|
| Mice, Mutant Strains | 22 | 2017 | 1750 | 0.430 |
Why?
|
| RNA, Messenger | 48 | 2021 | 12796 | 0.430 |
Why?
|
| Molecular Sequence Data | 66 | 2014 | 17644 | 0.420 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 1974 | 0.420 |
Why?
|
| Peripartum Period | 3 | 2021 | 137 | 0.410 |
Why?
|
| Genes, Mitochondrial | 1 | 2012 | 59 | 0.410 |
Why?
|
| GTP-Binding Proteins | 12 | 1997 | 951 | 0.400 |
Why?
|
| Genotype | 35 | 2023 | 13009 | 0.400 |
Why?
|
| Homozygote | 16 | 2017 | 1796 | 0.400 |
Why?
|
| Aortic Valve | 7 | 2019 | 1961 | 0.400 |
Why?
|
| Nucleic Acid Hybridization | 36 | 2009 | 1306 | 0.400 |
Why?
|
| T-Lymphocytes | 35 | 2016 | 10194 | 0.400 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2469 | 0.390 |
Why?
|
| AMP-Activated Protein Kinases | 12 | 2016 | 598 | 0.390 |
Why?
|
| Abnormalities, Multiple | 10 | 2020 | 1424 | 0.390 |
Why?
|
| Male | 204 | 2024 | 360736 | 0.390 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2024 | 2898 | 0.380 |
Why?
|
| Polymorphism, Genetic | 30 | 2006 | 4287 | 0.380 |
Why?
|
| Genome | 3 | 2022 | 1740 | 0.380 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 3 | 2022 | 162 | 0.370 |
Why?
|
| Tachycardia, Ventricular | 9 | 2014 | 1304 | 0.370 |
Why?
|
| Amino Acid Sequence | 62 | 2018 | 13449 | 0.360 |
Why?
|
| Expressed Sequence Tags | 1 | 2011 | 250 | 0.360 |
Why?
|
| Cloning, Molecular | 37 | 2000 | 4174 | 0.350 |
Why?
|
| Calcium Signaling | 7 | 2021 | 733 | 0.350 |
Why?
|
| Heart Failure | 18 | 2023 | 11674 | 0.350 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 2009 | 26 | 0.340 |
Why?
|
| Transcription, Genetic | 28 | 2024 | 7595 | 0.340 |
Why?
|
| DNA, Complementary | 9 | 2022 | 1992 | 0.340 |
Why?
|
| Deoxyribonucleases | 1 | 2011 | 211 | 0.340 |
Why?
|
| Mice, Knockout | 32 | 2024 | 14409 | 0.340 |
Why?
|
| Genomics | 10 | 2022 | 5820 | 0.340 |
Why?
|
| DNA | 62 | 2011 | 7219 | 0.340 |
Why?
|
| Cells, Cultured | 24 | 2024 | 18964 | 0.340 |
Why?
|
| Molecular Motor Proteins | 2 | 2007 | 105 | 0.330 |
Why?
|
| Immunoglobulin Light Chains | 15 | 1990 | 286 | 0.330 |
Why?
|
| Genetic Techniques | 3 | 2011 | 427 | 0.330 |
Why?
|
| Computational Biology | 3 | 2017 | 3517 | 0.320 |
Why?
|
| Female | 177 | 2024 | 392581 | 0.320 |
Why?
|
| Pericardium | 4 | 2018 | 675 | 0.310 |
Why?
|
| Immunoglobulin kappa-Chains | 13 | 1981 | 169 | 0.310 |
Why?
|
| Genome, Human | 8 | 2020 | 4425 | 0.310 |
Why?
|
| Connexins | 3 | 2005 | 352 | 0.310 |
Why?
|
| Gene Frequency | 6 | 2023 | 3647 | 0.310 |
Why?
|
| Wolff-Parkinson-White Syndrome | 4 | 2003 | 116 | 0.310 |
Why?
|
| Receptors, Cell Surface | 11 | 2009 | 2821 | 0.300 |
Why?
|
| Major Histocompatibility Complex | 16 | 1991 | 927 | 0.300 |
Why?
|
| DNA Copy Number Variations | 6 | 2022 | 2020 | 0.300 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2012 | 478 | 0.300 |
Why?
|
| Vertigo | 1 | 2009 | 202 | 0.300 |
Why?
|
| Forelimb | 2 | 2005 | 116 | 0.290 |
Why?
|
| Immunoglobulin J-Chains | 4 | 1996 | 26 | 0.290 |
Why?
|
| Adult | 100 | 2024 | 221148 | 0.290 |
Why?
|
| Sequence Deletion | 8 | 2018 | 1494 | 0.290 |
Why?
|
| beta 2-Microglobulin | 8 | 1986 | 329 | 0.290 |
Why?
|
| Catecholamines | 2 | 2009 | 386 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2871 | 0.280 |
Why?
|
| Cell Proliferation | 9 | 2024 | 10441 | 0.280 |
Why?
|
| Ventricular Remodeling | 7 | 2020 | 1266 | 0.280 |
Why?
|
| Steroid Hydroxylases | 7 | 1989 | 96 | 0.280 |
Why?
|
| Electrophysiology | 9 | 2007 | 1262 | 0.280 |
Why?
|
| Endothelial Cells | 6 | 2024 | 3541 | 0.280 |
Why?
|
| Transfection | 21 | 1994 | 5775 | 0.280 |
Why?
|
| GATA4 Transcription Factor | 2 | 2022 | 124 | 0.280 |
Why?
|
| Electrocardiography | 23 | 2020 | 6384 | 0.280 |
Why?
|
| Eustachian Tube | 1 | 2008 | 99 | 0.280 |
Why?
|
| Otitis Media with Effusion | 1 | 2008 | 115 | 0.270 |
Why?
|
| DNA Mutational Analysis | 22 | 2018 | 4110 | 0.270 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 3 | 2021 | 53 | 0.270 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2024 | 113 | 0.270 |
Why?
|
| Xenopus Proteins | 5 | 2002 | 434 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 1997 | 535 | 0.270 |
Why?
|
| Transforming Growth Factor beta | 3 | 2011 | 1960 | 0.270 |
Why?
|
| Calreticulin | 1 | 2007 | 114 | 0.270 |
Why?
|
| Child | 51 | 2024 | 80162 | 0.260 |
Why?
|
| Glycogen | 6 | 2016 | 251 | 0.260 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2024 | 790 | 0.260 |
Why?
|
| Histones | 5 | 2023 | 2580 | 0.260 |
Why?
|
| Trans-Activators | 6 | 2013 | 2856 | 0.260 |
Why?
|
| Adolescent | 57 | 2024 | 88313 | 0.260 |
Why?
|
| Death, Sudden, Cardiac | 5 | 2020 | 1555 | 0.250 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2006 | 56 | 0.250 |
Why?
|
| Middle Aged | 84 | 2024 | 220826 | 0.250 |
Why?
|
| Ear, Middle | 1 | 2008 | 339 | 0.250 |
Why?
|
| Software | 6 | 2020 | 4434 | 0.250 |
Why?
|
| Dependovirus | 5 | 2016 | 718 | 0.250 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2024 | 141 | 0.250 |
Why?
|
| Lod Score | 14 | 2006 | 602 | 0.250 |
Why?
|
| Heart Arrest, Induced | 2 | 2018 | 359 | 0.240 |
Why?
|
| Recombination, Genetic | 26 | 2000 | 1525 | 0.240 |
Why?
|
| DNA Restriction Enzymes | 23 | 1987 | 551 | 0.240 |
Why?
|
| Age of Onset | 13 | 2020 | 3304 | 0.240 |
Why?
|
| Single-Cell Analysis | 3 | 2022 | 2449 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 20 | 2020 | 15941 | 0.240 |
Why?
|
| Cardiovascular System | 3 | 2022 | 835 | 0.230 |
Why?
|
| Gene Expression | 11 | 2019 | 7584 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2020 | 361 | 0.230 |
Why?
|
| Proteins | 8 | 2024 | 6032 | 0.230 |
Why?
|
| Sternum | 1 | 2005 | 175 | 0.230 |
Why?
|
| Gene Targeting | 4 | 2014 | 838 | 0.230 |
Why?
|
| Hypertrophy | 3 | 2022 | 559 | 0.230 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2002 | 460 | 0.230 |
Why?
|
| Paracrine Communication | 2 | 2024 | 276 | 0.230 |
Why?
|
| Calcium Channel Blockers | 2 | 2010 | 694 | 0.230 |
Why?
|
| Nuclear Proteins | 7 | 2022 | 5794 | 0.230 |
Why?
|
| Beta-Globulins | 5 | 1983 | 27 | 0.220 |
Why?
|
| Heart Block | 5 | 2016 | 392 | 0.220 |
Why?
|
| Hypercalcemia | 4 | 1995 | 423 | 0.220 |
Why?
|
| Penetrance | 7 | 2020 | 388 | 0.220 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 2 | 1997 | 141 | 0.220 |
Why?
|
| Morphogenesis | 3 | 2011 | 741 | 0.220 |
Why?
|
| Amino Acid Substitution | 11 | 2014 | 1738 | 0.220 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 22 | 0.220 |
Why?
|
| Neoplasms | 9 | 2022 | 22164 | 0.220 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2018 | 736 | 0.220 |
Why?
|
| DNA, Mitochondrial | 3 | 2022 | 865 | 0.220 |
Why?
|
| Models, Genetic | 7 | 2019 | 3446 | 0.220 |
Why?
|
| Ventricular Dysfunction | 3 | 2011 | 144 | 0.220 |
Why?
|
| Diltiazem | 2 | 2010 | 131 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 14 | 6 | 2000 | 287 | 0.210 |
Why?
|
| Body Patterning | 2 | 2020 | 632 | 0.210 |
Why?
|
| Immunoglobulin A | 3 | 1996 | 980 | 0.210 |
Why?
|
| Heredity | 2 | 2020 | 148 | 0.210 |
Why?
|
| Verapamil | 3 | 2019 | 242 | 0.210 |
Why?
|
| MicroRNAs | 3 | 2013 | 3812 | 0.200 |
Why?
|
| Goldenhar Syndrome | 1 | 2022 | 39 | 0.200 |
Why?
|
| Micrognathism | 1 | 2022 | 63 | 0.200 |
Why?
|
| Syndrome | 18 | 2013 | 3268 | 0.200 |
Why?
|
| Plakophilins | 1 | 2022 | 32 | 0.200 |
Why?
|
| Child, Preschool | 27 | 2024 | 42254 | 0.200 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 77 | 0.200 |
Why?
|
| Mice, Inbred Strains | 13 | 2016 | 1762 | 0.200 |
Why?
|
| Genes, Neoplasm | 3 | 2021 | 370 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 30 | 2024 | 22163 | 0.200 |
Why?
|
| Dystrophin | 1 | 2023 | 283 | 0.200 |
Why?
|
| Methionine | 1 | 2024 | 572 | 0.200 |
Why?
|
| Heart Diseases | 4 | 2022 | 2785 | 0.200 |
Why?
|
| Congenital Abnormalities | 4 | 2015 | 709 | 0.200 |
Why?
|
| Heart Rate | 10 | 2016 | 4198 | 0.200 |
Why?
|
| Protein Biosynthesis | 12 | 2019 | 2114 | 0.200 |
Why?
|
| Troponin | 7 | 2010 | 501 | 0.200 |
Why?
|
| Fabry Disease | 2 | 2017 | 87 | 0.190 |
Why?
|
| Immunoglobulin Variable Region | 11 | 1999 | 419 | 0.190 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2016 | 515 | 0.190 |
Why?
|
| Haplotypes | 16 | 2020 | 2775 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 7 | 2016 | 347 | 0.190 |
Why?
|
| DNA-Binding Proteins | 10 | 2024 | 9606 | 0.190 |
Why?
|
| Cell Separation | 4 | 2021 | 1721 | 0.190 |
Why?
|
| Blotting, Northern | 10 | 2009 | 1545 | 0.190 |
Why?
|
| Protein Precursors | 6 | 1988 | 1133 | 0.190 |
Why?
|
| Aging | 8 | 2023 | 8705 | 0.180 |
Why?
|
| Poly U | 1 | 2020 | 12 | 0.180 |
Why?
|
| Poly G | 1 | 2020 | 7 | 0.180 |
Why?
|
| Macromolecular Substances | 15 | 1995 | 1435 | 0.180 |
Why?
|
| GATA6 Transcription Factor | 1 | 2020 | 50 | 0.180 |
Why?
|
| Rats | 32 | 2019 | 23742 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 1999 | 313 | 0.180 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 2538 | 0.180 |
Why?
|
| Aged | 53 | 2021 | 169235 | 0.180 |
Why?
|
| Heart Transplantation | 6 | 2023 | 3234 | 0.180 |
Why?
|
| Young Adult | 27 | 2024 | 59207 | 0.180 |
Why?
|
| Genetic Markers | 9 | 2024 | 2613 | 0.180 |
Why?
|
| Heart Atria | 10 | 2020 | 1347 | 0.170 |
Why?
|
| Actins | 9 | 2006 | 2050 | 0.170 |
Why?
|
| Repressor Proteins | 5 | 2023 | 2985 | 0.170 |
Why?
|
| Cell Line | 40 | 2016 | 15605 | 0.170 |
Why?
|
| Acetylation | 2 | 2021 | 1055 | 0.170 |
Why?
|
| Urea | 2 | 2019 | 444 | 0.170 |
Why?
|
| Ventricular Function, Left | 7 | 2020 | 3879 | 0.170 |
Why?
|
| Antigens, Surface | 11 | 1988 | 1609 | 0.170 |
Why?
|
| Potassium Channels | 3 | 2017 | 537 | 0.170 |
Why?
|
| Transcription Factor TFIID | 1 | 2020 | 150 | 0.170 |
Why?
|
| Case-Control Studies | 14 | 2024 | 22168 | 0.170 |
Why?
|
| Oxidoreductases | 1 | 2022 | 413 | 0.170 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2020 | 103 | 0.170 |
Why?
|
| YY1 Transcription Factor | 1 | 2019 | 60 | 0.170 |
Why?
|
| Oligonucleotides | 2 | 2022 | 582 | 0.170 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 68 | 0.170 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 92 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2019 | 110 | 0.170 |
Why?
|
| X Chromosome | 3 | 1999 | 816 | 0.160 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 100 | 0.160 |
Why?
|
| Paternal Age | 1 | 2019 | 87 | 0.160 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 7 | 1997 | 783 | 0.160 |
Why?
|
| Sinoatrial Node | 2 | 2018 | 99 | 0.160 |
Why?
|
| Extremities | 2 | 2024 | 867 | 0.160 |
Why?
|
| Signal Transduction | 17 | 2019 | 23441 | 0.160 |
Why?
|
| CpG Islands | 2 | 2020 | 1229 | 0.160 |
Why?
|
| Diaphragm | 1 | 2020 | 351 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2023 | 1135 | 0.160 |
Why?
|
| Genome-Wide Association Study | 10 | 2022 | 12688 | 0.160 |
Why?
|
| Genes, Regulator | 3 | 1991 | 374 | 0.160 |
Why?
|
| Calcium Channels, L-Type | 2 | 2015 | 242 | 0.160 |
Why?
|
| Coronary Artery Bypass | 4 | 2019 | 2189 | 0.160 |
Why?
|
| Cerebrum | 1 | 2020 | 132 | 0.160 |
Why?
|
| Myeloma Proteins | 7 | 1981 | 71 | 0.160 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 764 | 0.160 |
Why?
|
| DNA Helicases | 1 | 2024 | 851 | 0.160 |
Why?
|
| Serum Response Factor | 1 | 2018 | 78 | 0.160 |
Why?
|
| Transgenes | 4 | 2017 | 1010 | 0.160 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 4 | 2019 | 128 | 0.150 |
Why?
|
| Adenosine Triphosphate | 5 | 2019 | 1989 | 0.150 |
Why?
|
| Cardiovascular Diseases | 9 | 2016 | 15498 | 0.150 |
Why?
|
| Activin Receptors, Type II | 1 | 2019 | 123 | 0.150 |
Why?
|
| Ear | 2 | 2022 | 172 | 0.150 |
Why?
|
| Azepines | 1 | 2020 | 329 | 0.150 |
Why?
|
| Genetic Association Studies | 6 | 2020 | 2734 | 0.150 |
Why?
|
| Gene Dosage | 3 | 2020 | 1218 | 0.150 |
Why?
|
| Stress, Physiological | 3 | 2018 | 1403 | 0.150 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 362 | 0.150 |
Why?
|
| Bone Development | 1 | 2001 | 472 | 0.150 |
Why?
|
| Systole | 7 | 2019 | 937 | 0.150 |
Why?
|
| Cell-Matrix Junctions | 1 | 2018 | 21 | 0.150 |
Why?
|
| Blotting, Southern | 11 | 1996 | 780 | 0.150 |
Why?
|
| Growth Differentiation Factor 1 | 1 | 2017 | 6 | 0.150 |
Why?
|
| Mosaicism | 2 | 2020 | 475 | 0.150 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 1997 | 233 | 0.150 |
Why?
|
| Myofibrils | 3 | 2016 | 141 | 0.150 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 336 | 0.150 |
Why?
|
| Genetic Counseling | 3 | 2014 | 627 | 0.150 |
Why?
|
| Calcineurin | 6 | 2016 | 229 | 0.150 |
Why?
|
| Proteomics | 5 | 2024 | 3845 | 0.150 |
Why?
|
| Muscular Diseases | 3 | 2007 | 553 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 6 | 2018 | 1363 | 0.150 |
Why?
|
| HEK293 Cells | 5 | 2019 | 4278 | 0.150 |
Why?
|
| Intracranial Aneurysm | 3 | 2016 | 1285 | 0.150 |
Why?
|
| Animals, Newborn | 9 | 2018 | 2677 | 0.150 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2011 | 481 | 0.150 |
Why?
|
| Interleukin-11 | 1 | 2017 | 58 | 0.150 |
Why?
|
| Mice, 129 Strain | 2 | 2019 | 371 | 0.150 |
Why?
|
| Arrestins | 1 | 1997 | 73 | 0.150 |
Why?
|
| Thymidine Kinase | 3 | 1993 | 286 | 0.150 |
Why?
|
| JC Virus | 1 | 2018 | 87 | 0.150 |
Why?
|
| Genetic Heterogeneity | 3 | 2014 | 732 | 0.150 |
Why?
|
| Sirtuin 3 | 1 | 2018 | 67 | 0.150 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 1997 | 329 | 0.150 |
Why?
|
| Mutagenesis | 4 | 2018 | 1232 | 0.150 |
Why?
|
| Databases, Genetic | 4 | 2021 | 1742 | 0.150 |
Why?
|
| Myocarditis | 3 | 2024 | 787 | 0.140 |
Why?
|
| Receptors, Immunologic | 3 | 2022 | 1412 | 0.140 |
Why?
|
| Immunoglobulin Constant Regions | 8 | 1986 | 58 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 12 | 2018 | 5789 | 0.140 |
Why?
|
| Proteoglycans | 3 | 2016 | 803 | 0.140 |
Why?
|
| Stem Cells | 5 | 2012 | 3522 | 0.140 |
Why?
|
| Antigens, CD | 3 | 2009 | 4001 | 0.140 |
Why?
|
| Infant | 18 | 2024 | 36205 | 0.140 |
Why?
|
| Cyclosporine | 5 | 2014 | 778 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2017 | 119 | 0.140 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2010 | 773 | 0.140 |
Why?
|
| Cell Division | 2 | 2018 | 4466 | 0.140 |
Why?
|
| Cardiovascular Agents | 3 | 2019 | 840 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2016 | 302 | 0.140 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1997 | 242 | 0.140 |
Why?
|
| Secretory Component | 1 | 1996 | 16 | 0.140 |
Why?
|
| Actinin | 1 | 2018 | 163 | 0.140 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 133 | 0.140 |
Why?
|
| Adenosine Triphosphatases | 3 | 2020 | 834 | 0.140 |
Why?
|
| Nucleotides | 2 | 2018 | 454 | 0.140 |
Why?
|
| Migraine Disorders | 1 | 2009 | 1700 | 0.140 |
Why?
|
| DNA Primers | 12 | 2009 | 2820 | 0.140 |
Why?
|
| Hyperparathyroidism | 3 | 1995 | 337 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 12 | 1994 | 801 | 0.140 |
Why?
|
| Contractile Proteins | 3 | 2012 | 240 | 0.140 |
Why?
|
| RNA, Untranslated | 1 | 2020 | 459 | 0.140 |
Why?
|
| Anodontia | 3 | 2003 | 50 | 0.140 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2012 | 3613 | 0.140 |
Why?
|
| Vestibule, Labyrinth | 1 | 1998 | 234 | 0.140 |
Why?
|
| Chromatin | 7 | 2024 | 2960 | 0.140 |
Why?
|
| Gene Deletion | 5 | 2012 | 2667 | 0.130 |
Why?
|
| Propranolol | 3 | 2019 | 489 | 0.130 |
Why?
|
| Apoptosis | 4 | 2024 | 9488 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2017 | 629 | 0.130 |
Why?
|
| Tissue Engineering | 2 | 2024 | 1867 | 0.130 |
Why?
|
| Aortic Valve Stenosis | 3 | 2018 | 2009 | 0.130 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 211 | 0.130 |
Why?
|
| Sarcoplasmic Reticulum | 4 | 2013 | 163 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2024 | 682 | 0.130 |
Why?
|
| Homeostasis | 9 | 2020 | 3321 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 3 | 5 | 2020 | 322 | 0.130 |
Why?
|
| Thrombospondins | 1 | 2016 | 193 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 7 | 2015 | 638 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 7 | 5 | 2006 | 310 | 0.130 |
Why?
|
| Hemodynamics | 4 | 2020 | 4168 | 0.130 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 539 | 0.130 |
Why?
|
| Fibroblasts | 6 | 2024 | 4140 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2024 | 901 | 0.130 |
Why?
|
| Calcium Channels | 2 | 2017 | 620 | 0.130 |
Why?
|
| RNA, Small Interfering | 4 | 2020 | 3428 | 0.130 |
Why?
|
| RNA-Binding Proteins | 3 | 2020 | 1897 | 0.130 |
Why?
|
| Immunoglobulins | 7 | 2015 | 859 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2024 | 2124 | 0.130 |
Why?
|
| Embryo, Mammalian | 7 | 2008 | 1675 | 0.130 |
Why?
|
| Models, Molecular | 7 | 2017 | 5439 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4876 | 0.130 |
Why?
|
| Myosin Subfragments | 3 | 1997 | 20 | 0.120 |
Why?
|
| Models, Biological | 8 | 2020 | 9469 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 934 | 0.120 |
Why?
|
| Nucleic Acid Precursors | 5 | 1980 | 15 | 0.120 |
Why?
|
| Pressure | 4 | 2019 | 1155 | 0.120 |
Why?
|
| Restriction Mapping | 6 | 1995 | 852 | 0.120 |
Why?
|
| Paraffin Embedding | 1 | 2016 | 302 | 0.120 |
Why?
|
| Lectins | 1 | 2017 | 491 | 0.120 |
Why?
|
| Lidocaine | 1 | 2018 | 538 | 0.120 |
Why?
|
| Genetic Vectors | 7 | 2016 | 3395 | 0.120 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 158 | 0.120 |
Why?
|
| Binding Sites, Antibody | 3 | 1980 | 337 | 0.120 |
Why?
|
| Triazoles | 1 | 2020 | 903 | 0.120 |
Why?
|
| Hand Deformities, Congenital | 2 | 2012 | 174 | 0.120 |
Why?
|
| Cell Differentiation | 16 | 2024 | 11526 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6339 | 0.120 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1997 | 691 | 0.120 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 330 | 0.120 |
Why?
|
| Consanguinity | 2 | 2015 | 456 | 0.120 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2014 | 16 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2007 | 2748 | 0.120 |
Why?
|
| Hair | 1 | 1998 | 497 | 0.120 |
Why?
|
| 5' Flanking Region | 1 | 2014 | 31 | 0.120 |
Why?
|
| Inclusion Bodies | 1 | 1996 | 281 | 0.120 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 205 | 0.120 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 1206 | 0.120 |
Why?
|
| Histocompatibility Antigens Class II | 8 | 1989 | 1444 | 0.110 |
Why?
|
| Aorta | 3 | 2016 | 2041 | 0.110 |
Why?
|
| Templates, Genetic | 2 | 2020 | 189 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 1893 | 0.110 |
Why?
|
| Codon, Initiator | 1 | 2014 | 51 | 0.110 |
Why?
|
| Sequence Alignment | 8 | 2013 | 2179 | 0.110 |
Why?
|
| Family Health | 5 | 2014 | 1257 | 0.110 |
Why?
|
| Cytokinesis | 1 | 2015 | 171 | 0.110 |
Why?
|
| Infant, Newborn | 11 | 2024 | 26212 | 0.110 |
Why?
|
| Acrosome | 1 | 1993 | 10 | 0.110 |
Why?
|
| DNA, Neoplasm | 6 | 2015 | 1745 | 0.110 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2014 | 174 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2024 | 2163 | 0.110 |
Why?
|
| Diaphyses | 1 | 2013 | 65 | 0.110 |
Why?
|
| Models, Cardiovascular | 5 | 2013 | 981 | 0.110 |
Why?
|
| Nervous System Malformations | 1 | 2015 | 244 | 0.110 |
Why?
|
| Pancreas | 1 | 2020 | 1690 | 0.110 |
Why?
|
| Endocardial Cushions | 1 | 2013 | 12 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2018 | 829 | 0.110 |
Why?
|
| Microfilament Proteins | 2 | 2011 | 1134 | 0.110 |
Why?
|
| Tricuspid Valve | 1 | 2016 | 413 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2009 | 375 | 0.110 |
Why?
|
| Veins | 3 | 2024 | 768 | 0.110 |
Why?
|
| Disease Progression | 9 | 2015 | 13502 | 0.110 |
Why?
|
| Flagella | 1 | 1993 | 99 | 0.110 |
Why?
|
| Hypocalcemia | 1 | 1994 | 201 | 0.110 |
Why?
|
| Gene Rearrangement | 1 | 2018 | 1125 | 0.110 |
Why?
|
| Organogenesis | 1 | 2014 | 215 | 0.110 |
Why?
|
| Atrioventricular Node | 2 | 2007 | 180 | 0.110 |
Why?
|
| Microscopy, Electron | 10 | 2007 | 2561 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 1171 | 0.100 |
Why?
|
| Chickens | 5 | 2018 | 859 | 0.100 |
Why?
|
| Genes, p53 | 1 | 2015 | 712 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2008 | 192 | 0.100 |
Why?
|
| Fetal Development | 1 | 2018 | 769 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2018 | 621 | 0.100 |
Why?
|
| Muscle, Skeletal | 8 | 2020 | 4946 | 0.100 |
Why?
|
| Fetus | 2 | 2016 | 1864 | 0.100 |
Why?
|
| Protein Conformation | 6 | 2020 | 3969 | 0.100 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1994 | 207 | 0.100 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 123 | 0.100 |
Why?
|
| Aged, 80 and over | 20 | 2021 | 58956 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2023 | 2057 | 0.100 |
Why?
|
| Ubiquitins | 1 | 2014 | 366 | 0.100 |
Why?
|
| In Situ Hybridization | 6 | 2013 | 1900 | 0.100 |
Why?
|
| Receptors, Calcium-Sensing | 6 | 1998 | 318 | 0.100 |
Why?
|
| RNA Interference | 3 | 2020 | 2831 | 0.100 |
Why?
|
| Genetics, Population | 2 | 2022 | 939 | 0.100 |
Why?
|
| Algorithms | 4 | 2021 | 14026 | 0.100 |
Why?
|
| Endonucleases | 2 | 2014 | 371 | 0.100 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 732 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2011 | 223 | 0.100 |
Why?
|
| Crosses, Genetic | 6 | 2010 | 750 | 0.100 |
Why?
|
| Streptococcus pyogenes | 1 | 2014 | 292 | 0.100 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2013 | 247 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2001 | 822 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 4414 | 0.100 |
Why?
|
| Adrenal Glands | 2 | 1992 | 552 | 0.100 |
Why?
|
| Sex Characteristics | 3 | 2019 | 2637 | 0.100 |
Why?
|
| Genetic Structures | 1 | 2011 | 12 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 1188 | 0.100 |
Why?
|
| Adrenal Cortex Neoplasms | 3 | 1990 | 161 | 0.100 |
Why?
|
| Osteopontin | 1 | 2013 | 301 | 0.100 |
Why?
|
| Pigments, Biological | 1 | 1991 | 52 | 0.100 |
Why?
|
| DNA Methylation | 3 | 2023 | 4391 | 0.100 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2011 | 63 | 0.100 |
Why?
|
| Laminin | 1 | 1993 | 408 | 0.100 |
Why?
|
| Testis | 2 | 1993 | 794 | 0.100 |
Why?
|
| Molecular Probe Techniques | 2 | 2011 | 111 | 0.100 |
Why?
|
| Myocardial Infarction | 6 | 2019 | 11458 | 0.100 |
Why?
|
| Apolipoproteins | 1 | 2013 | 326 | 0.100 |
Why?
|
| Brachyura | 1 | 2011 | 18 | 0.100 |
Why?
|
| Pacemaker, Artificial | 1 | 2017 | 808 | 0.100 |
Why?
|
| Plasmids | 7 | 1989 | 2269 | 0.100 |
Why?
|
| Enchondromatosis | 1 | 2011 | 14 | 0.100 |
Why?
|
| Muscular Dystrophies | 2 | 2013 | 390 | 0.100 |
Why?
|
| Molecular Conformation | 3 | 2006 | 545 | 0.090 |
Why?
|
| Aneurysm, Ruptured | 1 | 2016 | 463 | 0.090 |
Why?
|
| Action Potentials | 3 | 2017 | 1834 | 0.090 |
Why?
|
| Zebrafish | 4 | 2018 | 3007 | 0.090 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2011 | 29 | 0.090 |
Why?
|
| Genomic Library | 4 | 2009 | 189 | 0.090 |
Why?
|
| Lipids | 1 | 2022 | 3340 | 0.090 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 3 | 2003 | 506 | 0.090 |
Why?
|
| Energy Metabolism | 6 | 2020 | 2881 | 0.090 |
Why?
|
| Tenosynovitis | 1 | 1991 | 57 | 0.090 |
Why?
|
| Kinetics | 8 | 2021 | 6374 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 8545 | 0.090 |
Why?
|
| Adrenal Cortex | 3 | 1988 | 134 | 0.090 |
Why?
|
| SOS1 Protein | 1 | 2010 | 40 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2020 | 1456 | 0.090 |
Why?
|
| Proteome | 1 | 2021 | 1862 | 0.090 |
Why?
|
| Survival Analysis | 7 | 2018 | 10089 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 17 | 2011 | 6086 | 0.090 |
Why?
|
| Phosphorylation | 11 | 2015 | 8320 | 0.090 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2010 | 103 | 0.090 |
Why?
|
| Peptide Fragments | 7 | 2010 | 5115 | 0.090 |
Why?
|
| Thioredoxins | 1 | 2011 | 202 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 229 | 0.090 |
Why?
|
| Atrial Fibrillation | 5 | 2016 | 5127 | 0.090 |
Why?
|
| Bacterial Proteins | 3 | 2014 | 3846 | 0.090 |
Why?
|
| Ribose-Phosphate Pyrophosphokinase | 1 | 2010 | 8 | 0.090 |
Why?
|
| Blood Pressure | 4 | 2011 | 8487 | 0.090 |
Why?
|
| Chediak-Higashi Syndrome | 1 | 1990 | 10 | 0.090 |
Why?
|
| Binding Sites | 7 | 2020 | 6055 | 0.090 |
Why?
|
| Calcinosis | 2 | 2016 | 1469 | 0.090 |
Why?
|
| Apolipoprotein C-III | 1 | 2011 | 210 | 0.090 |
Why?
|
| Resistin | 1 | 2011 | 172 | 0.090 |
Why?
|
| Mutant Proteins | 2 | 2015 | 491 | 0.090 |
Why?
|
| Macrophages | 3 | 2024 | 5768 | 0.090 |
Why?
|
| Procollagen | 1 | 2010 | 187 | 0.090 |
Why?
|
| Noonan Syndrome | 1 | 2010 | 120 | 0.090 |
Why?
|
| Codon | 5 | 2019 | 602 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 1390 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 2000 | 375 | 0.090 |
Why?
|
| Smad4 Protein | 1 | 2011 | 191 | 0.090 |
Why?
|
| Postprandial Period | 1 | 2011 | 315 | 0.080 |
Why?
|
| Physical Conditioning, Animal | 2 | 2005 | 365 | 0.080 |
Why?
|
| DNA, Recombinant | 10 | 1988 | 455 | 0.080 |
Why?
|
| Ultrasonography | 7 | 2014 | 5970 | 0.080 |
Why?
|
| Simplexvirus | 1 | 1993 | 803 | 0.080 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1989 | 40 | 0.080 |
Why?
|
| Lymphocytes | 4 | 1996 | 2611 | 0.080 |
Why?
|
| Transformation, Genetic | 7 | 2002 | 192 | 0.080 |
Why?
|
| Myopathies, Nemaline | 1 | 2009 | 73 | 0.080 |
Why?
|
| Lipase | 1 | 2011 | 325 | 0.080 |
Why?
|
| Cytoskeleton | 2 | 2009 | 1170 | 0.080 |
Why?
|
| E2F3 Transcription Factor | 1 | 2008 | 36 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 675 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2015 | 862 | 0.080 |
Why?
|
| Heart Valves | 1 | 2011 | 284 | 0.080 |
Why?
|
| Spermatozoa | 1 | 1993 | 630 | 0.080 |
Why?
|
| Protein Subunits | 3 | 2011 | 943 | 0.080 |
Why?
|
| Complement C4 | 2 | 1992 | 244 | 0.080 |
Why?
|
| Chromosomes, Human, 6-12 and X | 2 | 1985 | 77 | 0.080 |
Why?
|
| Twins, Dizygotic | 1 | 2009 | 236 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 1997 | 430 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2009 | 147 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1033 | 0.080 |
Why?
|
| Losartan | 1 | 2010 | 265 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2019 | 3630 | 0.080 |
Why?
|
| Zebrafish Proteins | 3 | 2016 | 1014 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 1037 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2455 | 0.080 |
Why?
|
| Papillomaviridae | 1 | 2014 | 1119 | 0.080 |
Why?
|
| Ouabain | 1 | 1988 | 247 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 10 | 2016 | 9179 | 0.080 |
Why?
|
| Fingers | 1 | 1991 | 507 | 0.080 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 4 | 1992 | 221 | 0.080 |
Why?
|
| Open Reading Frames | 3 | 2020 | 815 | 0.070 |
Why?
|
| Autistic Disorder | 1 | 2017 | 1220 | 0.070 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2018 | 1555 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 321 | 0.070 |
Why?
|
| Angiotensin II | 2 | 2023 | 848 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 1938 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2007 | 484 | 0.070 |
Why?
|
| Leukemia, Lymphoid | 5 | 1987 | 310 | 0.070 |
Why?
|
| Magnesium | 2 | 2010 | 808 | 0.070 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2007 | 30 | 0.070 |
Why?
|
| Codon, Nonsense | 2 | 2016 | 285 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 2863 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 13637 | 0.070 |
Why?
|
| Lymphocyte Activation | 4 | 2003 | 5490 | 0.070 |
Why?
|
| Cohort Studies | 12 | 2020 | 41446 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 2001 | 1058 | 0.070 |
Why?
|
| Avian Proteins | 2 | 1999 | 80 | 0.070 |
Why?
|
| Iceland | 2 | 2020 | 184 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 8 | 1987 | 1784 | 0.070 |
Why?
|
| Up-Regulation | 4 | 2018 | 4124 | 0.070 |
Why?
|
| Gene Knock-In Techniques | 3 | 2014 | 421 | 0.070 |
Why?
|
| Blood Proteins | 1 | 1992 | 1180 | 0.070 |
Why?
|
| Prevalence | 7 | 2022 | 15717 | 0.070 |
Why?
|
| Electron Transport Complex III | 1 | 2007 | 31 | 0.070 |
Why?
|
| Stromal Cells | 2 | 2024 | 1330 | 0.070 |
Why?
|
| Lac Operon | 1 | 2007 | 237 | 0.070 |
Why?
|
| Tendons | 1 | 1991 | 558 | 0.070 |
Why?
|
| Limb Buds | 2 | 2024 | 76 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2013 | 1144 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4575 | 0.070 |
Why?
|
| Spermatocytes | 1 | 1986 | 40 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 2009 | 328 | 0.070 |
Why?
|
| Clone Cells | 10 | 1994 | 1659 | 0.070 |
Why?
|
| Bartter Syndrome | 1 | 1986 | 23 | 0.070 |
Why?
|
| Rats, Inbred SHR | 3 | 2011 | 186 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 613 | 0.070 |
Why?
|
| Parathyroid Glands | 4 | 1995 | 518 | 0.070 |
Why?
|
| Hair Diseases | 1 | 2007 | 72 | 0.070 |
Why?
|
| Telemetry | 1 | 2007 | 199 | 0.070 |
Why?
|
| Time Factors | 12 | 2016 | 39975 | 0.070 |
Why?
|
| Epitopes | 11 | 1990 | 2507 | 0.070 |
Why?
|
| Leukemia, Experimental | 1 | 1986 | 225 | 0.070 |
Why?
|
| Cytokines | 2 | 2017 | 7392 | 0.070 |
Why?
|
| Hyperthyroidism | 1 | 1988 | 292 | 0.070 |
Why?
|
| Environment | 1 | 2012 | 1122 | 0.070 |
Why?
|
| Diastole | 4 | 2007 | 782 | 0.070 |
Why?
|
| Collagen Type I | 2 | 2010 | 616 | 0.070 |
Why?
|
| Antibody Specificity | 6 | 1997 | 1060 | 0.070 |
Why?
|
| Genes, Immunoglobulin | 3 | 1995 | 285 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 5 | 2003 | 785 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 400 | 0.070 |
Why?
|
| Exercise Test | 2 | 2005 | 2129 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 1998 | 386 | 0.060 |
Why?
|
| Hearing Loss | 1 | 2013 | 783 | 0.060 |
Why?
|
| Species Specificity | 7 | 2014 | 2416 | 0.060 |
Why?
|
| Phospholipids | 1 | 1989 | 786 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1458 | 0.060 |
Why?
|
| Protein Structure, Secondary | 2 | 2006 | 1229 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2008 | 477 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 4 | 2018 | 906 | 0.060 |
Why?
|
| B-Lymphocytes | 8 | 1987 | 4764 | 0.060 |
Why?
|
| Hyperostosis, Cortical, Congenital | 1 | 2005 | 5 | 0.060 |
Why?
|
| Adipocytes | 2 | 2024 | 1194 | 0.060 |
Why?
|
| Age Factors | 9 | 2019 | 18400 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2015 | 350 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2012 | 928 | 0.060 |
Why?
|
| Sirolimus | 2 | 2023 | 1533 | 0.060 |
Why?
|
| Peptides | 5 | 2011 | 4345 | 0.060 |
Why?
|
| Cytotoxicity, Immunologic | 8 | 1990 | 1351 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2013 | 1135 | 0.060 |
Why?
|
| Intercellular Junctions | 1 | 2005 | 195 | 0.060 |
Why?
|
| Chromosomes | 4 | 1984 | 577 | 0.060 |
Why?
|
| Leukemia Virus, Murine | 1 | 1985 | 94 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2014 | 2448 | 0.060 |
Why?
|
| Metallothionein | 1 | 1985 | 61 | 0.060 |
Why?
|
| Glycolysis | 2 | 2024 | 836 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 15 | 1993 | 6215 | 0.060 |
Why?
|
| Carpal Bones | 1 | 2005 | 75 | 0.060 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2011 | 696 | 0.060 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2005 | 43 | 0.060 |
Why?
|
| Tacrolimus | 2 | 2000 | 733 | 0.060 |
Why?
|
| Chromosome Disorders | 4 | 2013 | 499 | 0.060 |
Why?
|
| Jews | 2 | 1997 | 364 | 0.060 |
Why?
|
| Liver | 5 | 1995 | 7532 | 0.060 |
Why?
|
| Natriuresis | 1 | 1984 | 105 | 0.060 |
Why?
|
| RNA, Transfer | 3 | 1975 | 292 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2010 | 1486 | 0.060 |
Why?
|
| Ear, Inner | 1 | 2008 | 425 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 5840 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2022 | 1320 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2012 | 1723 | 0.060 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2005 | 101 | 0.060 |
Why?
|
| Microscopy, Atomic Force | 2 | 2019 | 253 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 191 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8999 | 0.060 |
Why?
|
| Methylation | 3 | 2013 | 1083 | 0.060 |
Why?
|
| Ovalbumin | 3 | 2003 | 677 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 3734 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 4 | 2007 | 3792 | 0.060 |
Why?
|
| Autophagy | 2 | 2022 | 1326 | 0.060 |
Why?
|
| Arm | 2 | 1997 | 590 | 0.060 |
Why?
|
| Adenosine Monophosphate | 1 | 2005 | 230 | 0.060 |
Why?
|
| Tetralogy of Fallot | 1 | 2009 | 631 | 0.060 |
Why?
|
| Pantothenate Kinase-Associated Neurodegeneration | 1 | 2003 | 13 | 0.060 |
Why?
|
| Mesoderm | 2 | 2024 | 673 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2024 | 841 | 0.060 |
Why?
|
| Mitogens | 2 | 1996 | 230 | 0.060 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2003 | 27 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39117 | 0.060 |
Why?
|
| Chromosome Deletion | 7 | 1989 | 1387 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2007 | 2119 | 0.060 |
Why?
|
| Constriction | 1 | 2003 | 171 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2017 | 3312 | 0.060 |
Why?
|
| Chick Embryo | 4 | 2014 | 982 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2010 | 1693 | 0.050 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2009 | 732 | 0.050 |
Why?
|
| Constriction, Pathologic | 2 | 2019 | 1097 | 0.050 |
Why?
|
| Urban Population | 1 | 2011 | 2036 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 1988 | 667 | 0.050 |
Why?
|
| Pregnancy | 9 | 2022 | 29862 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2024 | 2510 | 0.050 |
Why?
|
| Long QT Syndrome | 2 | 1999 | 467 | 0.050 |
Why?
|
| Reference Values | 4 | 2018 | 4921 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2014 | 3096 | 0.050 |
Why?
|
| Hyperaldosteronism | 1 | 1986 | 247 | 0.050 |
Why?
|
| Ramipril | 1 | 2023 | 102 | 0.050 |
Why?
|
| Vascular Grafting | 1 | 2024 | 162 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2023 | 200 | 0.050 |
Why?
|
| alpha-Galactosidase | 2 | 2017 | 57 | 0.050 |
Why?
|
| Atrial Function | 2 | 2016 | 99 | 0.050 |
Why?
|
| Mitochondria | 4 | 2022 | 3623 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 457 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1699 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 113 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 3447 | 0.050 |
Why?
|
| Cell Survival | 3 | 2016 | 5790 | 0.050 |
Why?
|
| Elasticity | 4 | 2009 | 655 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3082 | 0.050 |
Why?
|
| DNA Probes | 4 | 1992 | 544 | 0.050 |
Why?
|
| Protein Binding | 7 | 2017 | 9352 | 0.050 |
Why?
|
| Brain | 6 | 2024 | 27107 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2018 | 1094 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2020 | 6479 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3202 | 0.050 |
Why?
|
| Hybrid Cells | 4 | 1992 | 422 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2023 | 473 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2706 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2022 | 247 | 0.050 |
Why?
|
| Ion Channels | 2 | 1997 | 1040 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 3490 | 0.050 |
Why?
|
| Glutamine | 3 | 2018 | 577 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2020 | 9645 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2014 | 5036 | 0.050 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2002 | 32 | 0.050 |
Why?
|
| Hippocampus | 4 | 1999 | 3763 | 0.050 |
Why?
|
| Myosin Light Chains | 1 | 2002 | 121 | 0.050 |
Why?
|
| Vestibular Diseases | 1 | 2004 | 230 | 0.050 |
Why?
|
| Quail | 2 | 2018 | 40 | 0.050 |
Why?
|
| Nails, Malformed | 1 | 2001 | 34 | 0.050 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2001 | 67 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2016 | 2918 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 1988 | 1168 | 0.050 |
Why?
|
| Plasmacytoma | 7 | 1980 | 171 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 3779 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 1994 | 779 | 0.050 |
Why?
|
| Leukemia | 3 | 1986 | 1522 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2001 | 3612 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 4 | 1990 | 649 | 0.050 |
Why?
|
| Risk | 3 | 2020 | 9612 | 0.050 |
Why?
|
| Kidney | 5 | 2017 | 7049 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2007 | 542 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 2116 | 0.050 |
Why?
|
| Atlases as Topic | 1 | 2022 | 248 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2013 | 20093 | 0.050 |
Why?
|
| Connexin 43 | 2 | 2017 | 200 | 0.050 |
Why?
|
| Automation, Laboratory | 1 | 2021 | 102 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2016 | 4650 | 0.050 |
Why?
|
| Minoxidil | 1 | 2000 | 34 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 420 | 0.050 |
Why?
|
| Retinitis Pigmentosa | 1 | 2004 | 397 | 0.050 |
Why?
|
| Ligands | 2 | 2019 | 3271 | 0.050 |
Why?
|
| Lymphoma | 5 | 1994 | 1901 | 0.050 |
Why?
|
| Oligonucleotide Probes | 2 | 1991 | 417 | 0.050 |
Why?
|
| Muscle Cells | 2 | 2016 | 195 | 0.040 |
Why?
|
| Prognosis | 7 | 2019 | 29620 | 0.040 |
Why?
|
| Interleukin-2 | 2 | 1999 | 1891 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 14664 | 0.040 |
Why?
|
| Globins | 5 | 1978 | 403 | 0.040 |
Why?
|
| Ataxia Telangiectasia | 3 | 1985 | 107 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2003 | 583 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 2892 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2002 | 195 | 0.040 |
Why?
|
| Glioma | 1 | 2015 | 3455 | 0.040 |
Why?
|
| Anthracyclines | 1 | 2022 | 284 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 2020 | 138 | 0.040 |
Why?
|
| Structure-Activity Relationship | 5 | 2007 | 3076 | 0.040 |
Why?
|
| Singapore | 1 | 2020 | 291 | 0.040 |
Why?
|
| Spironolactone | 1 | 2023 | 412 | 0.040 |
Why?
|
| Survival Rate | 5 | 2014 | 12720 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2002 | 469 | 0.040 |
Why?
|
| Atrial Myosins | 1 | 1999 | 3 | 0.040 |
Why?
|
| Cosmids | 3 | 1989 | 105 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2021 | 1317 | 0.040 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2019 | 58 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2019 | 90 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 8 | 1993 | 1746 | 0.040 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6395 | 0.040 |
Why?
|
| Follistatin-Related Proteins | 1 | 2019 | 48 | 0.040 |
Why?
|
| Bundle of His | 1 | 1999 | 102 | 0.040 |
Why?
|
| Gene Fusion | 1 | 2022 | 356 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2023 | 1006 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2024 | 4549 | 0.040 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2000 | 84 | 0.040 |
Why?
|
| Arteries | 1 | 2024 | 1124 | 0.040 |
Why?
|
| Prospective Studies | 9 | 2019 | 54415 | 0.040 |
Why?
|
| Sheep | 1 | 2001 | 1440 | 0.040 |
Why?
|
| Audiometry | 1 | 1999 | 253 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2000 | 1165 | 0.040 |
Why?
|
| Tooth Abnormalities | 1 | 1998 | 56 | 0.040 |
Why?
|
| Multigene Family | 1 | 2002 | 1077 | 0.040 |
Why?
|
| Azaserine | 1 | 2018 | 8 | 0.040 |
Why?
|
| Linoleic Acid | 1 | 2019 | 158 | 0.040 |
Why?
|
| Rats, Inbred Strains | 4 | 1988 | 2089 | 0.040 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 2 | 2013 | 21 | 0.040 |
Why?
|
| Thyroid Diseases | 1 | 2002 | 386 | 0.040 |
Why?
|
| Ulna | 1 | 1999 | 134 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2002 | 898 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2022 | 426 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 14 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2024 | 1096 | 0.040 |
Why?
|
| Angiotensin Amide | 1 | 2017 | 4 | 0.040 |
Why?
|
| Risk Factors | 10 | 2020 | 74167 | 0.040 |
Why?
|
| Cardioplegic Solutions | 1 | 2018 | 123 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2003 | 657 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 243 | 0.040 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.040 |
Why?
|
| Hypophosphatemia, Familial | 1 | 1998 | 32 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2024 | 1600 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2019 | 427 | 0.040 |
Why?
|
| Necrosis | 2 | 2013 | 1608 | 0.040 |
Why?
|
| Viscosity | 3 | 2004 | 336 | 0.040 |
Why?
|
| Pericytes | 1 | 2020 | 293 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2013 | 3407 | 0.040 |
Why?
|
| Body Surface Potential Mapping | 1 | 1999 | 228 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 1993 | 3702 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 1999 | 698 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2018 | 147 | 0.040 |
Why?
|
| HLA Antigens | 4 | 2000 | 1371 | 0.040 |
Why?
|
| Neomycin | 4 | 1997 | 92 | 0.040 |
Why?
|
| Apocrine Glands | 1 | 1997 | 32 | 0.040 |
Why?
|
| Activins | 1 | 2019 | 210 | 0.040 |
Why?
|
| Biopsy | 3 | 2017 | 6766 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 3 | 2002 | 902 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 520 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 266 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1132 | 0.040 |
Why?
|
| Computer-Aided Design | 1 | 2019 | 300 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 1983 | 1560 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2004 | 1088 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 1613 | 0.030 |
Why?
|
| Mitochondria, Liver | 1 | 2017 | 190 | 0.030 |
Why?
|
| Denmark | 1 | 2019 | 771 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2017 | 169 | 0.030 |
Why?
|
| Causality | 1 | 2023 | 1243 | 0.030 |
Why?
|
| Genitalia | 1 | 1997 | 113 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 437 | 0.030 |
Why?
|
| Propylthiouracil | 2 | 2004 | 68 | 0.030 |
Why?
|
| Stress, Mechanical | 2 | 2015 | 1674 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2018 | 649 | 0.030 |
Why?
|
| Chloride Channels | 1 | 1998 | 221 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 6 | 1989 | 899 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 552 | 0.030 |
Why?
|
| Fluorescence | 1 | 2019 | 756 | 0.030 |
Why?
|
| Persia | 1 | 1996 | 7 | 0.030 |
Why?
|
| Face | 1 | 2022 | 1026 | 0.030 |
Why?
|
| Cations | 1 | 1997 | 238 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1996 | 127 | 0.030 |
Why?
|
| Stroke Volume | 4 | 2018 | 5497 | 0.030 |
Why?
|
| Workflow | 1 | 2021 | 851 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2018 | 961 | 0.030 |
Why?
|
| Germ Cells | 1 | 2020 | 634 | 0.030 |
Why?
|
| Genetic Engineering | 3 | 2016 | 933 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1998 | 463 | 0.030 |
Why?
|
| Immunoglobulin gamma-Chains | 3 | 1987 | 33 | 0.030 |
Why?
|
| Israel | 2 | 2014 | 726 | 0.030 |
Why?
|
| Kallmann Syndrome | 1 | 1997 | 139 | 0.030 |
Why?
|
| Epithelium | 1 | 2020 | 1603 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 1999 | 543 | 0.030 |
Why?
|
| Ribosomes | 1 | 2019 | 501 | 0.030 |
Why?
|
| Cricetinae | 5 | 1994 | 2425 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 468 | 0.030 |
Why?
|
| Cattle | 4 | 1995 | 3848 | 0.030 |
Why?
|
| Deafness | 1 | 2000 | 459 | 0.030 |
Why?
|
| Myositis, Inclusion Body | 1 | 1997 | 145 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 12456 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2141 | 0.030 |
Why?
|
| Protein Folding | 2 | 2014 | 870 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2015 | 395 | 0.030 |
Why?
|
| Rabbits | 3 | 2008 | 4779 | 0.030 |
Why?
|
| Tetany | 1 | 1994 | 13 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 2 | 2010 | 871 | 0.030 |
Why?
|
| Adipokines | 1 | 2017 | 310 | 0.030 |
Why?
|
| MSX1 Transcription Factor | 3 | 2001 | 53 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15838 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2023 | 2687 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2015 | 191 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2011 | 283 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1994 | 110 | 0.030 |
Why?
|
| Bile | 1 | 1995 | 298 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 1996 | 271 | 0.030 |
Why?
|
| Europe | 2 | 2009 | 3423 | 0.030 |
Why?
|
| Chimera | 1 | 1996 | 453 | 0.030 |
Why?
|
| Dimerization | 3 | 2002 | 891 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 625 | 0.030 |
Why?
|
| Acne Vulgaris | 1 | 2000 | 358 | 0.030 |
Why?
|
| Molecular Biology | 1 | 2018 | 578 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1995 | 410 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 2 | 1988 | 544 | 0.030 |
Why?
|
| Uncertainty | 1 | 2019 | 754 | 0.030 |
Why?
|
| Arthritis | 1 | 2000 | 682 | 0.030 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1998 | 335 | 0.030 |
Why?
|
| Proline | 4 | 2003 | 457 | 0.030 |
Why?
|
| Ventricular Function | 2 | 2004 | 406 | 0.030 |
Why?
|
| Coliphages | 5 | 1978 | 121 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 4 | 2009 | 6132 | 0.030 |
Why?
|
| Chromosome Aberrations | 3 | 1999 | 1771 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2005 | 2568 | 0.030 |
Why?
|
| Lebanon | 1 | 2015 | 245 | 0.030 |
Why?
|
| Parathyroid Hormone | 2 | 1998 | 1803 | 0.030 |
Why?
|
| China | 1 | 2020 | 2366 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2014 | 146 | 0.030 |
Why?
|
| Recombinant Proteins | 4 | 2006 | 6532 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2013 | 63 | 0.030 |
Why?
|
| Tibia | 2 | 2013 | 1070 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1996 | 754 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2013 | 107 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2011 | 2005 | 0.030 |
Why?
|
| Actomyosin | 2 | 2005 | 109 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 345 | 0.030 |
Why?
|
| Immune Tolerance | 2 | 1993 | 2300 | 0.030 |
Why?
|
| Lactation | 1 | 1996 | 397 | 0.030 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 2 | 1993 | 111 | 0.030 |
Why?
|
| Alkaptonuria | 1 | 1993 | 13 | 0.030 |
Why?
|
| Video Recording | 1 | 2019 | 966 | 0.030 |
Why?
|
| Isometric Contraction | 2 | 2004 | 151 | 0.030 |
Why?
|
| Spain | 1 | 2015 | 489 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2007 | 3597 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2016 | 2555 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1792 | 0.030 |
Why?
|
| Cardiac Output | 1 | 1996 | 837 | 0.030 |
Why?
|
| Myositis | 1 | 2016 | 271 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 1996 | 327 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 92 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2013 | 47 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 615 | 0.030 |
Why?
|
| Motor Activity | 2 | 2013 | 2711 | 0.030 |
Why?
|
| Milk | 1 | 1996 | 443 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 1561 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1997 | 959 | 0.030 |
Why?
|
| Genes, Developmental | 1 | 2013 | 38 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2020 | 874 | 0.030 |
Why?
|
| Sodium | 3 | 1987 | 1588 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 3 | 1985 | 965 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 902 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2013 | 126 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1994 | 252 | 0.030 |
Why?
|
| Myoblasts, Skeletal | 1 | 2013 | 75 | 0.030 |
Why?
|
| Physical Exertion | 1 | 1996 | 667 | 0.030 |
Why?
|
| Hybridomas | 4 | 1990 | 442 | 0.030 |
Why?
|
| Eye Proteins | 2 | 2008 | 633 | 0.030 |
Why?
|
| Mice, Inbred NOD | 2 | 1999 | 1827 | 0.030 |
Why?
|
| Documentation | 1 | 2019 | 897 | 0.030 |
Why?
|
| Nasal Mucosa | 1 | 1996 | 415 | 0.030 |
Why?
|
| Cryotherapy | 1 | 1994 | 159 | 0.030 |
Why?
|
| Breast | 2 | 1999 | 1966 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1994 | 462 | 0.030 |
Why?
|
| Oocytes | 2 | 1995 | 1166 | 0.030 |
Why?
|
| Heart Septal Defects | 1 | 1994 | 191 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2014 | 305 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2014 | 1791 | 0.030 |
Why?
|
| Thymus Gland | 2 | 1988 | 1243 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2000 | 1141 | 0.030 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 1992 | 14 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 1996 | 412 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2013 | 174 | 0.030 |
Why?
|
| CHO Cells | 2 | 1994 | 1388 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2005 | 418 | 0.030 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1992 | 66 | 0.030 |
Why?
|
| Arginine | 3 | 2004 | 933 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 128 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2013 | 12143 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 6935 | 0.030 |
Why?
|
| Virus Integration | 1 | 2014 | 304 | 0.030 |
Why?
|
| Dogs | 2 | 1995 | 3839 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 1841 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2005 | 12970 | 0.030 |
Why?
|
| Base Pair Mismatch | 1 | 2012 | 92 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2003 | 1469 | 0.030 |
Why?
|
| Electroporation | 1 | 1994 | 255 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2003 | 3159 | 0.030 |
Why?
|
| Neurons | 4 | 2020 | 9462 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1990 | 168 | 0.030 |
Why?
|
| Genes, Recessive | 2 | 2013 | 628 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 1993 | 259 | 0.030 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 2 | 2009 | 43 | 0.020 |
Why?
|
| Bandages | 1 | 1994 | 269 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2011 | 138 | 0.020 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 1756 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1998 | 809 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2019 | 23990 | 0.020 |
Why?
|
| Hepacivirus | 1 | 1999 | 1337 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1834 | 0.020 |
Why?
|
| Sequence Tagged Sites | 1 | 2011 | 96 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2002 | 1909 | 0.020 |
Why?
|
| Response Elements | 1 | 2013 | 309 | 0.020 |
Why?
|
| Smell | 1 | 2013 | 259 | 0.020 |
Why?
|
| Enterotoxins | 1 | 1993 | 367 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3614 | 0.020 |
Why?
|
| Protein Sorting Signals | 2 | 1989 | 279 | 0.020 |
Why?
|
| Meningoencephalitis | 2 | 1989 | 83 | 0.020 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 133 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2003 | 122 | 0.020 |
Why?
|
| Papillary Muscles | 2 | 2004 | 192 | 0.020 |
Why?
|
| Fetal Heart | 1 | 2013 | 281 | 0.020 |
Why?
|
| COS Cells | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Mothers | 1 | 2022 | 2192 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2011 | 69 | 0.020 |
Why?
|
| Cell Count | 1 | 2015 | 1835 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2015 | 786 | 0.020 |
Why?
|
| Biological Transport | 1 | 1995 | 2092 | 0.020 |
Why?
|
| Graft vs Host Reaction | 1 | 1991 | 103 | 0.020 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1990 | 16 | 0.020 |
Why?
|
| Molecular Weight | 5 | 1987 | 2188 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 3 | 1990 | 346 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1997 | 1148 | 0.020 |
Why?
|
| Knee Prosthesis | 1 | 1994 | 395 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 1997 | 1173 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2023 | 3061 | 0.020 |
Why?
|
| Ethylnitrosourea | 1 | 2010 | 51 | 0.020 |
Why?
|
| Potassium | 2 | 2002 | 1311 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1994 | 963 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 1999 | 1435 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2000 | 2382 | 0.020 |
Why?
|
| RNA, Heterogeneous Nuclear | 2 | 1980 | 2 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2010 | 162 | 0.020 |
Why?
|
| Infertility, Male | 1 | 1993 | 396 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3712 | 0.020 |
Why?
|
| Mice, Inbred AKR | 2 | 1986 | 104 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 2 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 506 | 0.020 |
Why?
|
| Receptors, Melanocortin | 1 | 2009 | 23 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1994 | 1055 | 0.020 |
Why?
|
| Autoimmune Diseases | 2 | 2001 | 2248 | 0.020 |
Why?
|
| Metabolome | 1 | 2016 | 987 | 0.020 |
Why?
|
| RNA, Viral | 2 | 1975 | 2846 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2009 | 231 | 0.020 |
Why?
|
| Marfan Syndrome | 1 | 2011 | 236 | 0.020 |
Why?
|
| Synapses | 1 | 1999 | 1769 | 0.020 |
Why?
|
| Herpes Zoster | 2 | 1989 | 253 | 0.020 |
Why?
|
| Digoxin | 1 | 1990 | 246 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2013 | 915 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 1989 | 294 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2013 | 551 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2021 | 80582 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 4575 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2009 | 51 | 0.020 |
Why?
|
| Hypertension | 1 | 2009 | 8542 | 0.020 |
Why?
|
| Systems Biology | 1 | 2013 | 481 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 855 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1668 | 0.020 |
Why?
|
| Lateral Line System | 1 | 2008 | 11 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 442 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1998 | 10766 | 0.020 |
Why?
|
| Placenta | 1 | 1998 | 1708 | 0.020 |
Why?
|
| Organ Specificity | 2 | 2003 | 1967 | 0.020 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 4430 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 749 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2001 | 2019 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2009 | 129 | 0.020 |
Why?
|
| Neoplasms, Experimental | 5 | 1980 | 1230 | 0.020 |
Why?
|
| Calcimycin | 1 | 1988 | 213 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 662 | 0.020 |
Why?
|
| Hepatitis C | 1 | 1999 | 1584 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2009 | 317 | 0.020 |
Why?
|
| Teratoma | 2 | 1989 | 404 | 0.020 |
Why?
|
| Azacitidine | 1 | 1990 | 336 | 0.020 |
Why?
|
| Filtration | 1 | 2009 | 228 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1098 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2009 | 134 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 1988 | 142 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 633 | 0.020 |
Why?
|
| Lysine | 1 | 2013 | 992 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 1985 | 1116 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 2013 | 701 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3667 | 0.020 |
Why?
|
| Incidence | 2 | 2019 | 21341 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5914 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 942 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2009 | 211 | 0.020 |
Why?
|
| Killer Cells, Natural | 2 | 1988 | 2203 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2012 | 773 | 0.020 |
Why?
|
| Intestinal Mucosa | 2 | 1996 | 3030 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 1970 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 1989 | 159 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2016 | 2769 | 0.020 |
Why?
|
| Skeleton | 1 | 2007 | 29 | 0.020 |
Why?
|
| Isoleucine | 1 | 2007 | 110 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2760 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 695 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1987 | 159 | 0.020 |
Why?
|
| Cell Movement | 2 | 2014 | 5203 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 2488 | 0.020 |
Why?
|
| Substrate Cycling | 1 | 2007 | 7 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 1179 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2811 | 0.020 |
Why?
|
| Pyrazines | 1 | 2013 | 1201 | 0.020 |
Why?
|
| Antibodies | 2 | 2013 | 2421 | 0.020 |
Why?
|
| Biological Evolution | 4 | 1982 | 1072 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 1993 | 1155 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1994 | 1471 | 0.020 |
Why?
|
| Brazil | 1 | 2011 | 1230 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 836 | 0.020 |
Why?
|
| Tetracycline | 1 | 2007 | 216 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9320 | 0.020 |
Why?
|
| Escherichia coli | 3 | 1980 | 4218 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 1987 | 328 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 578 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 2 | 2002 | 927 | 0.020 |
Why?
|
| Acetyltransferases | 1 | 1988 | 231 | 0.020 |
Why?
|
| Social Behavior | 1 | 2013 | 1134 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2161 | 0.020 |
Why?
|
| Indoles | 1 | 2015 | 1832 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1509 | 0.020 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2009 | 293 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 271 | 0.020 |
Why?
|
| Desoxycorticosterone | 1 | 1986 | 46 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 7045 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15650 | 0.020 |
Why?
|
| Chromosome Banding | 3 | 1992 | 260 | 0.020 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1986 | 64 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2851 | 0.020 |
Why?
|
| Optical Tweezers | 1 | 2007 | 85 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 1994 | 1007 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2065 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 36423 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 1529 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2017 | 2092 | 0.020 |
Why?
|
| Catheter Ablation | 2 | 2016 | 2752 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1994 | 1806 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1991 | 999 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2009 | 897 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 183 | 0.020 |
Why?
|
| Mitochondrial Myopathies | 1 | 2006 | 50 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 1993 | 4808 | 0.020 |
Why?
|
| Biotransformation | 1 | 2006 | 166 | 0.020 |
Why?
|
| Complement C2 | 1 | 1985 | 70 | 0.020 |
Why?
|
| Genetic Code | 2 | 1983 | 138 | 0.020 |
Why?
|
| Yeasts | 1 | 2007 | 279 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 3093 | 0.020 |
Why?
|
| Complement Factor B | 1 | 1985 | 72 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 386 | 0.020 |
Why?
|
| Research Design | 1 | 2002 | 6178 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 463 | 0.020 |
Why?
|
| Hair Cells, Auditory | 1 | 2008 | 381 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2019 | 64651 | 0.020 |
Why?
|
| Poly A | 2 | 1983 | 181 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 1878 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 614 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 4021 | 0.020 |
Why?
|
| Ribonucleases | 3 | 1994 | 277 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 1985 | 174 | 0.020 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2006 | 123 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 1989 | 1249 | 0.020 |
Why?
|
| Immune Sera | 1 | 1985 | 613 | 0.020 |
Why?
|
| Patient Participation | 1 | 2014 | 1444 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 180 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2019 | 12330 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2000 | 5919 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2113 | 0.020 |
Why?
|
| Autopsy | 1 | 2009 | 1007 | 0.020 |
Why?
|
| Ribonucleotides | 2 | 1975 | 114 | 0.020 |
Why?
|
| Knee Joint | 1 | 1994 | 1673 | 0.020 |
Why?
|
| Regeneration | 1 | 2014 | 1511 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 2016 | 0.020 |
Why?
|
| Genes, Synthetic | 1 | 1985 | 88 | 0.020 |
Why?
|
| Autoradiography | 1 | 1985 | 730 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1985 | 815 | 0.020 |
Why?
|
| Natriuretic Agents | 1 | 1984 | 57 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 746 | 0.010 |
Why?
|
| Sex Factors | 3 | 2008 | 10548 | 0.010 |
Why?
|
| Venezuela | 1 | 2004 | 74 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 1241 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 2 | 1983 | 513 | 0.010 |
Why?
|
| Thyroxine | 1 | 1988 | 668 | 0.010 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2005 | 61 | 0.010 |
Why?
|
| Chlorides | 1 | 1987 | 665 | 0.010 |
Why?
|
| HLA-DR Antigens | 2 | 1983 | 631 | 0.010 |
Why?
|
| Immunologic Capping | 1 | 1984 | 30 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 1 | 1984 | 113 | 0.010 |
Why?
|
| PAX9 Transcription Factor | 1 | 2003 | 14 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 3441 | 0.010 |
Why?
|
| Learning | 1 | 2013 | 1740 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2022 | 12951 | 0.010 |
Why?
|
| Dyneins | 1 | 2004 | 124 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2008 | 702 | 0.010 |
Why?
|
| Procainamide | 1 | 2003 | 56 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2009 | 1021 | 0.010 |
Why?
|
| Disease Management | 1 | 2014 | 2507 | 0.010 |
Why?
|
| Dermis | 1 | 2005 | 202 | 0.010 |
Why?
|
| Epilepsy | 1 | 2019 | 3290 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1987 | 621 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 2004 | 421 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1997 | 11073 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2007 | 580 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1983 | 134 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 1997 | 3837 | 0.010 |
Why?
|
| Muscle Strength | 1 | 2008 | 624 | 0.010 |
Why?
|
| Base Composition | 1 | 1983 | 290 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 737 | 0.010 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2005 | 241 | 0.010 |
Why?
|
| Radiography | 2 | 2005 | 6966 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2013 | 2910 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 1989 | 799 | 0.010 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 789 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8223 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2003 | 151 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4172 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1984 | 305 | 0.010 |
Why?
|
| DNA Repair | 1 | 2012 | 2045 | 0.010 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 94 | 0.010 |
Why?
|
| Fibula | 1 | 2005 | 266 | 0.010 |
Why?
|
| Cholesterol | 1 | 2011 | 2902 | 0.010 |
Why?
|
| Gestational Age | 1 | 1991 | 3576 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 878 | 0.010 |
Why?
|
| Introns | 2 | 1997 | 981 | 0.010 |
Why?
|
| Cytoplasm | 2 | 1984 | 1511 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 7389 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 461 | 0.010 |
Why?
|
| Graft Survival | 1 | 1993 | 3819 | 0.010 |
Why?
|
| Hemolysis | 1 | 1984 | 424 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2012 | 2977 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 147 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1985 | 416 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2011 | 2631 | 0.010 |
Why?
|
| Collagen | 1 | 2010 | 2638 | 0.010 |
Why?
|
| Gene Conversion | 1 | 1982 | 67 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 687 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2002 | 89 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1540 | 0.010 |
Why?
|
| Trophoblasts | 1 | 1983 | 224 | 0.010 |
Why?
|
| Antigens, Neoplasm | 3 | 1987 | 1994 | 0.010 |
Why?
|
| Glucose | 1 | 2013 | 4347 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1987 | 1164 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 565 | 0.010 |
Why?
|
| Anthropometry | 1 | 2006 | 1349 | 0.010 |
Why?
|
| Drug Resistance | 2 | 1984 | 1595 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16979 | 0.010 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2000 | 21 | 0.010 |
Why?
|
| Antibody Diversity | 1 | 1981 | 72 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2003 | 435 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1987 | 1491 | 0.010 |
Why?
|
| Disulfides | 3 | 1987 | 465 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 429 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1984 | 755 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1991 | 154 | 0.010 |
Why?
|
| Phosphorylcholine | 1 | 1981 | 153 | 0.010 |
Why?
|
| Pertussis Toxin | 2 | 1991 | 176 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1988 | 1947 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2005 | 611 | 0.010 |
Why?
|
| Phosphates | 1 | 2004 | 770 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2019 | 6937 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 2002 | 439 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2003 | 819 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2003 | 554 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2001 | 209 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 14599 | 0.010 |
Why?
|
| Lamins | 1 | 1999 | 37 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 2000 | 95 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 1407 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2015 | 3482 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8641 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2013 | 6238 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 2002 | 447 | 0.010 |
Why?
|
| Water | 2 | 2002 | 1410 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1984 | 869 | 0.010 |
Why?
|
| Data Collection | 1 | 2009 | 3322 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2003 | 1571 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2243 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2000 | 384 | 0.010 |
Why?
|
| Paralysis | 1 | 2001 | 250 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12938 | 0.010 |
Why?
|
| Mice, Congenic | 1 | 1999 | 97 | 0.010 |
Why?
|
| Choline | 1 | 1981 | 515 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 892 | 0.010 |
Why?
|
| Family | 1 | 2010 | 3197 | 0.010 |
Why?
|
| Isoantibodies | 1 | 1983 | 674 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2004 | 1440 | 0.010 |
Why?
|
| Antibody-Producing Cells | 1 | 1978 | 140 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1988 | 1286 | 0.010 |
Why?
|
| RNA, Neoplasm | 2 | 1980 | 750 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26112 | 0.010 |
Why?
|
| Anxiety | 1 | 2013 | 4572 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 1999 | 225 | 0.010 |
Why?
|
| Adenosine | 1 | 2003 | 808 | 0.010 |
Why?
|
| Disease Susceptibility | 2 | 1996 | 1793 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1998 | 40 | 0.010 |
Why?
|
| Adenosine Diphosphate Ribose | 2 | 1989 | 69 | 0.010 |
Why?
|
| Subacute Sclerosing Panencephalitis | 2 | 1988 | 26 | 0.010 |
Why?
|
| Electromyography | 1 | 2003 | 1393 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1978 | 103 | 0.010 |
Why?
|
| Melanoma | 1 | 2016 | 5709 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 2 | 1994 | 1706 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8179 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 1863 | 0.010 |
Why?
|
| Multifactorial Inheritance | 1 | 2006 | 1392 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 1999 | 293 | 0.010 |
Why?
|
| Weight Loss | 2 | 2001 | 2683 | 0.010 |
Why?
|
| Afghanistan | 1 | 1997 | 78 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 1990 | 0.010 |
Why?
|
| Iraq | 1 | 1997 | 93 | 0.010 |
Why?
|
| Spermine | 1 | 1997 | 70 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 656 | 0.010 |
Why?
|
| United States | 3 | 2016 | 72339 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2011 | 3963 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1998 | 327 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1997 | 189 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 2254 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1062 | 0.010 |
Why?
|
| Multiple Sclerosis | 2 | 1990 | 3224 | 0.010 |
Why?
|
| Immunization | 1 | 2001 | 1227 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1999 | 578 | 0.010 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 1996 | 72 | 0.010 |
Why?
|
| Alagille Syndrome | 1 | 1996 | 45 | 0.010 |
Why?
|
| Retroviridae | 1 | 1999 | 850 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 2 | 1987 | 30 | 0.010 |
Why?
|
| Isoenzymes | 2 | 1999 | 1688 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3110 | 0.010 |
Why?
|
| France | 1 | 1997 | 498 | 0.010 |
Why?
|
| Body Weight | 2 | 2002 | 4618 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13255 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1997 | 595 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1988 | 618 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 1996 | 285 | 0.010 |
Why?
|
| Lung | 1 | 2013 | 9995 | 0.010 |
Why?
|
| Bone Diseases, Developmental | 1 | 1995 | 131 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1997 | 336 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 202 | 0.010 |
Why?
|
| Serine | 2 | 1975 | 830 | 0.010 |
Why?
|
| Managed Care Programs | 1 | 2000 | 940 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1989 | 3163 | 0.010 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 1993 | 12 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1999 | 605 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 4234 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1999 | 1093 | 0.010 |
Why?
|
| Cytoplasmic Granules | 2 | 1986 | 574 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1998 | 866 | 0.010 |
Why?
|
| Vesicular stomatitis Indiana virus | 2 | 1984 | 93 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1997 | 1647 | 0.010 |
Why?
|
| Ionomycin | 1 | 1993 | 110 | 0.010 |
Why?
|
| Kidney Calculi | 1 | 1998 | 463 | 0.010 |
Why?
|
| Perfusion | 1 | 1998 | 1373 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 1993 | 246 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1995 | 286 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15262 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 1987 | 557 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1989 | 4248 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1985 | 915 | 0.010 |
Why?
|
| Fundus Oculi | 1 | 1994 | 556 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1997 | 1414 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1995 | 1152 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2265 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 1997 | 840 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 817 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1999 | 2201 | 0.010 |
Why?
|
| Solubility | 1 | 1994 | 1091 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1991 | 87 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1997 | 1736 | 0.010 |
Why?
|
| Canada | 1 | 1997 | 2120 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1887 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 240 | 0.010 |
Why?
|
| Microtubules | 1 | 1997 | 1074 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1994 | 657 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1995 | 1878 | 0.010 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1991 | 153 | 0.010 |
Why?
|
| Pancreatic Diseases | 1 | 1993 | 343 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1990 | 94 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 21012 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 7825 | 0.010 |
Why?
|
| Electrophoresis | 2 | 1986 | 234 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 1984 | 7856 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 1991 | 433 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1991 | 1085 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1990 | 246 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1991 | 467 | 0.010 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1969 | 51 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1991 | 618 | 0.010 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1988 | 31 | 0.010 |
Why?
|
| Thrombin | 1 | 1991 | 590 | 0.010 |
Why?
|
| Isoantigens | 1 | 1991 | 552 | 0.000 |
Why?
|
| Dendritic Cells | 2 | 1994 | 2746 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1980 | 3576 | 0.000 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1969 | 169 | 0.000 |
Why?
|
| Spleen | 1 | 1994 | 2295 | 0.000 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1989 | 262 | 0.000 |
Why?
|
| Phosphotransferases | 1 | 1969 | 303 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 3769 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1999 | 3155 | 0.000 |
Why?
|
| Probability | 1 | 1993 | 2478 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1969 | 416 | 0.000 |
Why?
|
| Range of Motion, Articular | 1 | 1994 | 1586 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 176 | 0.000 |
Why?
|
| Lymphocytosis | 1 | 1988 | 121 | 0.000 |
Why?
|
| Stroke | 1 | 2009 | 9756 | 0.000 |
Why?
|
| Islets of Langerhans | 1 | 1993 | 1346 | 0.000 |
Why?
|
| tau Proteins | 1 | 1997 | 2095 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 2001 | 11106 | 0.000 |
Why?
|
| Karyotyping | 1 | 1988 | 1171 | 0.000 |
Why?
|
| Fibrinolysis | 1 | 1987 | 332 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1986 | 865 | 0.000 |
Why?
|
| Rats, Mutant Strains | 1 | 1985 | 60 | 0.000 |
Why?
|
| Rhodopsin | 1 | 1986 | 203 | 0.000 |
Why?
|
| Equipment Design | 1 | 1994 | 3509 | 0.000 |
Why?
|
| Protein Multimerization | 1 | 1990 | 983 | 0.000 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1984 | 17 | 0.000 |
Why?
|
| Corticosterone | 1 | 1986 | 305 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1993 | 1458 | 0.000 |
Why?
|
| Fibrin | 1 | 1987 | 507 | 0.000 |
Why?
|
| Antigens | 1 | 1990 | 1446 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1984 | 176 | 0.000 |
Why?
|
| Rodent Diseases | 1 | 1984 | 53 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 2000 | 4330 | 0.000 |
Why?
|
| Neprilysin | 1 | 1987 | 478 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1994 | 2672 | 0.000 |
Why?
|
| HLA-A2 Antigen | 1 | 1984 | 211 | 0.000 |
Why?
|
| Thymoma | 1 | 1986 | 187 | 0.000 |
Why?
|
| Kidney Glomerulus | 1 | 1986 | 568 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1994 | 5868 | 0.000 |
Why?
|
| Metaphase | 1 | 1984 | 145 | 0.000 |
Why?
|
| Viral Proteins | 1 | 1991 | 1803 | 0.000 |
Why?
|
| Trinitrobenzenes | 1 | 1983 | 46 | 0.000 |
Why?
|
| Naphthalenesulfonates | 1 | 1983 | 15 | 0.000 |
Why?
|
| Pain, Postoperative | 1 | 1994 | 1737 | 0.000 |
Why?
|
| Lactoylglutathione Lyase | 1 | 1983 | 13 | 0.000 |
Why?
|
| Muscular Dystrophy, Oculopharyngeal | 1 | 1963 | 8 | 0.000 |
Why?
|
| Haptens | 1 | 1983 | 163 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1991 | 2932 | 0.000 |
Why?
|
| Retina | 1 | 1994 | 2658 | 0.000 |
Why?
|
| Lymphopenia | 1 | 1985 | 280 | 0.000 |
Why?
|
| Thymus Neoplasms | 1 | 1986 | 273 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1983 | 526 | 0.000 |
Why?
|
| Progesterone | 1 | 1986 | 742 | 0.000 |
Why?
|
| Inflammation | 1 | 2001 | 10762 | 0.000 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 1980 | 46 | 0.000 |
Why?
|
| Skin | 1 | 1994 | 4481 | 0.000 |
Why?
|
| Influenza A virus | 1 | 1984 | 458 | 0.000 |
Why?
|
| Surface Properties | 1 | 1983 | 1160 | 0.000 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1993 | 4370 | 0.000 |
Why?
|
| Polyribosomes | 1 | 1980 | 109 | 0.000 |
Why?
|
| Eyelids | 1 | 1963 | 278 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1986 | 974 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1985 | 1398 | 0.000 |
Why?
|
| Trypsin | 1 | 1980 | 496 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1991 | 4445 | 0.000 |
Why?
|
| Analgesics, Opioid | 1 | 1994 | 3804 | 0.000 |
Why?
|
| Mitosis | 1 | 1983 | 1187 | 0.000 |
Why?
|
| Methods | 1 | 1978 | 1074 | 0.000 |
Why?
|
| Translocation, Genetic | 1 | 1983 | 1393 | 0.000 |
Why?
|
| Deglutition Disorders | 1 | 1963 | 625 | 0.000 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 1977 | 82 | 0.000 |
Why?
|
| Lysogeny | 1 | 1973 | 67 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1973 | 100 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1973 | 213 | 0.000 |
Why?
|
| Hydrolysis | 1 | 1973 | 664 | 0.000 |
Why?
|
| DNA Replication | 1 | 1977 | 1418 | 0.000 |
Why?
|
| Phosphoglucomutase | 1 | 1969 | 6 | 0.000 |
Why?
|
| Phosphorylase Kinase | 1 | 1969 | 9 | 0.000 |
Why?
|
| Plasma Volume | 1 | 1969 | 31 | 0.000 |
Why?
|
| Myoglobinuria | 1 | 1969 | 22 | 0.000 |
Why?
|
| Malate Dehydrogenase | 1 | 1969 | 40 | 0.000 |
Why?
|
| Clinical Enzyme Tests | 1 | 1969 | 113 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1969 | 411 | 0.000 |
Why?
|
| Pyruvate Kinase | 1 | 1969 | 189 | 0.000 |
Why?
|
| Creatine Kinase | 1 | 1969 | 686 | 0.000 |
Why?
|
| Muscles | 1 | 1969 | 1576 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1979 | 5146 | 0.000 |
Why?
|
| Alcoholism | 1 | 1969 | 1973 | 0.000 |
Why?
|